Ana Fernandez Cruz
Overview
Explore the profile of Ana Fernandez Cruz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Ruiz M, Caston J, Del Pozo J, Carratala J, Fortun J, Salavert M, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 Aug;
42(8):442-452.
PMID: 39112116
Pneumonia continues to be one of the most frequent infectious syndromes and a relevant cause of death and health resources utilization. The OPENIN ("Optimización de procesos clínicos para el diagnóstico...
2.
Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, et al.
Elife
. 2023 Jan;
12.
PMID: 36715684
Background: In this international multicenter study, we aimed to determine the independent risk factors associated with increased 30 day mortality and the impact of cancer and novel treatment modalities in...
3.
Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, et al.
medRxiv
. 2022 Sep;
PMID: 36097568
Background: In this international multicenter study we aimed to determine the independent risk factors associated with increased 30-day mortality and the impact of novel treatment modalities in a large group...
4.
Mejia-Chew C, Carver P, Rutjanawech S, Camargo L, Fernandes R, Belga S, et al.
Clin Infect Dis
. 2022 Jul;
76(3):e995-e1003.
PMID: 35879465
Background: Risk factors for nontuberculous mycobacteria (NTM) infections after solid organ transplant (SOT) are not well characterized. Here we aimed to describe these factors. Methods: Retrospective, multinational, 1:2 matched case-control...
5.
Lavilla Olleros C, Garcia C, Bendala Estrada A, Munoz A, Wikman Jogersen P, Fernandez Cruz A, et al.
PLoS One
. 2022 Jan;
17(1):e0261711.
PMID: 35061713
Objective: To describe the impact of different doses of corticosteroids on the evolution of patients with COVID-19 pneumonia, based on the potential benefit of the non-genomic mechanism of these drugs...
6.
Rubio-Rivas M, Mora-Lujan J, Montero A, Aguilar Garcia J, Mendez Bailon M, Fernandez Cruz A, et al.
J Gen Intern Med
. 2021 Oct;
37(1):168-175.
PMID: 34664188
Background: The inflammatory cascade is the main cause of death in COVID-19 patients. Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which patients to administer it...
7.
Sancho-Lopez A, Caballero-Bermejo A, Ruiz-Antoran B, Munez Rubio E, Garcia Gasalla M, Buades J, et al.
Infect Dis Ther
. 2021 Oct;
10(4):2735-2748.
PMID: 34658006
Introduction: SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 (COVID-19). High Interleukin-6 (IL6) blood levels have been...
8.
Balaz D, Wikman-Jorgensen P, Giner Galvan V, Rubio-Rivas M, de Miguel Campo B, Lopez M, et al.
J Clin Med
. 2021 Oct;
10(19).
PMID: 34640628
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive...
9.
Diaz-Simon R, Lalueza A, Lora-Tamayo J, Rubio-Rivas M, Mendo C, Taboada Martinez M, et al.
J Gen Intern Med
. 2021 Aug;
36(10):3080-3087.
PMID: 34379281
Background: Age is a risk factor for COVID severity. Most studies performed in hospitalized patients with SARS-CoV2 infection have shown an over-representation of older patients and consequently few have properly...
10.
Caballero Bermejo A, Ruiz-Antoran B, Fernandez Cruz A, Diago Sempere E, Callejas Diaz A, Munez Rubio E, et al.
Trials
. 2020 Sep;
21(1):794.
PMID: 32938496
Objectives: In some patients, acute, life-threatening respiratory injury produced by viruses such as SARS-CoV and other viral pneumonia are associated with an over-exuberant cytokine release. Elevated levels of blood IL-6...